Therapeutic targeting of VEGFR2 in HBV-associated hepatocellular carcinoma

Lancet Gastroenterol Hepatol. 2021 Jul;6(7):515-516. doi: 10.1016/S2468-1253(21)00134-5. Epub 2021 May 8.
No abstract available

Publication types

  • Comment

MeSH terms

  • Carcinoma, Hepatocellular*
  • Hepatitis B virus
  • Humans
  • Liver Neoplasms*